Charles River Laboratories International, Inc. (Form: 8-K)  

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

     
Date of Report (Date of Earliest Event Reported):   May 6, 2014

Charles River Laboratories International, Inc.
__________________________________________
(Exact name of registrant as specified in its charter)

     
Delaware 001-15943 06-1397316
_____________________
(State or other jurisdiction 		_____________
(Commission 		______________
(I.R.S. Employer
of incorporation) File Number) Identification No.)
      
251 Ballardvale St., Wilmington, Massachusetts   01887
_________________________________
(Address of principal executive offices) 		  ___________
(Zip Code)
     
Registrant’s telephone number, including area code:   781-222-6000

Not Applicable
______________________________________________
Former name or former address, if changed since last report

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

[  ]  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[  ]  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[  ]  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[  ]  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Top of the Form

Item 5.07. Submission of Matters to a Vote of Security Holders

Charles River Laboratories International, Inc. (Company) held its Annual Meeting of Shareholders on May 6, 2014. For more information on the following proposals, see the Company’s proxy statement dated April 1, 2014. At the Company’s Annual Meeting, the following proposals were adopted by the votes specified below:

(a) The following nine (9) directors were elected to serve until our 2015 Annual Meeting of Shareholders and received the number of votes listed opposite each of their names below:

                         
 
   Number of Shares   Number of Shares   Broker Non-Votes
 
   Voted For   Withheld        
James C. Foster
     41,467,948       836,466       2,569,797  
Robert J. Bertolini
     42,201,948       102,466       2,569,797  
Stephen D. Chubb
     40,063,597       2,240,817       2,569,797  
Deborah T. Kochevar
     36,116,541       6,187,873       2,569,797  
George E. Massaro
     41,756,559       547,855       2,569,797  
George M. Milne, Jr.
     41,537,215       767,199       2,569,797  
Cr. Richard Reese
     40,533,823       1,770,591       2,569,797  
Craig B. Thompson
     42,153,788       150,626       2,569,797  
Richard F. Wallman
     37,362,153       4,942,261       2,569,797  

(b) The shareholders approved, on an advisory, non-binding basis, the compensation of our named executive officers.

                         
For
  Against   Abstain   Broker Non-Votes
39,063,883
    1,551,143       1,689,388       2,569,797  

(d) The shareholders approved the ratification of the appointment of PricewaterhouseCoopers LLP as our independent auditors for fiscal 2014.

                         
For
  Against   Abstain   Broker Non-Votes
44,295,298
    568,343       10,570       0  

Computershare Trust Company, N.A., our transfer agent, acted as independent proxy tabulator and Inspector of Election at the Annual Meeting of Shareholders.

Top of the Form

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

         
    Charles River Laboratories International, Inc.
          
May 9, 2014   By:   Karen Queen Stern
       
        Name: Karen Queen Stern
        Title: Assistant Secretary and Corporate Counsel